Safety Study of CC312 in Autoimmune Disease Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety Study of CC312 in Autoimmune Disease Patients	Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, anemia, arthritic joint disease, arthropathy, autoimmune disease, autoimmune hemolytic anemia, blood coagulation disease, blood platelet disease, connective tissue disorder, hematologic disorder, hemolytic anemia, hemorrhagic disease, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, purpura, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic lupus erythematosus, systemic sclerosis, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy	Recruiting	Early phase 1	2025-09-17		NCT06888960

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
CytoCares Inc	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences	Tianjin	China	1